Much progress has been made in the last decade in identifying genes responsible for
antifungal resistance in Candida albicans. Attention has focused on five major C. albicans …

The development of newer antifungal drugs is creating new potential combination therapies
to combat the dismal mortality rate associated with invasive aspergillosis (IA). The efficacy of …

Leishmaniasis is a parasitic neglected tropical disease caused by various species of
Leishmania parasite. Despite tremendous advancements in the therapeutic sector and drug …

Rifaximin, a rifamycin derivative, was evaluated in vitro to assess its spectrum and potency
against a wide variety of bacteria, yeasts, viruses, and parasites. High concentrations of …

Despite advances in surgical technique and immunosuppressive regimens, infections
remain major causes of morbidity and mortality in patients undergoing solid-organ …

Fluvastatin, a cholesterol-lowering drug, exhibited minimal activity (MICs of 64 to> 128
microg/ml) against Candida species and Cryptococcus neoformans. When fluvastatin was …

Berberine with and without fluconazole was tested by an agar disk diffusion assay in which
clinical isolates of Candida albicans were applied onto yeast extract-peptone-dextrose agar …

The combination of fluconazole with either ibuprofen, sodium salicylate, or propylparaben
resulted in synergistic activity (fractional inhibitory index,< 0.5) against Candida albicans …

BACKGROUND: Frequent opportunist fungal infections and the resistance to available
antifungal drugs promoted the development of new alternatives for treatment, like antifungal …

Twenty-eight neutropenic (< 500 granulocytes/gl) adults with microbiologically or
histologically proven systemic mycosis were randomly assigned to receive either …